NEWS
Redwire to Test 3D Bioprinted Liver Tissue in Space, Reinforcing the Company’s Focus on Transforming the Future of Organ Transplantation on Earth
Redwire (NYSE: RDW) is launching a groundbreaking experiment to the International Space Station (ISS) to analyze the effects of microgravity on tissue bioprinting and culturing. In collaboration with Wake Forest Institute of Regenerative Medicine, Redwire will culture 36 bioprinted vascularized liver tissue constructs in space. This initiative aims to determine if liver cells bioprinted on Earth can form functioning blood vessels in microgravity, potentially addressing the global organ shortage.
Redwire has made significant progress in space biotech, successfully bioprinting human knee meniscus and heart tissue samples in space. The company is also launching four drug manufacturing experiments in its PIL-BOX system, marking its third spaceflight mission in 10 months. These experiments will launch to the ISS aboard the Northrop Grumman NG-21 cargo resupply mission in early August 2024.
Redwire has made significant progress in space biotech, successfully bioprinting human knee meniscus and heart tissue samples in space. The company is also launching four drug manufacturing experiments in its PIL-BOX system, marking its third spaceflight mission in 10 months. These experiments will launch to the ISS aboard the Northrop Grumman NG-21 cargo resupply mission in early August 2024.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
2747Followers
108Following
29KVisitors
Follow
jebadia frobe : my gf is a transplant recipient and this kind of innovation and science is needed and sooo important.
she had a liver disease that she was born with subsequently she did not only have one transplant but 4 from birth to the age of 16. this kind of technology would have been able to create a perfect match and would have saved her so much trauma. maybe it's wrong to make stock trading investments personal but for this company I'll allow it. thank you RDW
Jaguar8 OP jebadia frobe : No it’s ok to have some personal preference for stocks. I myself have preference to biotech stocks because one, I’m a medical provider and second I’m battling stage 4 cancer, and third my family has history of CA, DM, heart disease. So any advancements for diseases I really rejoice at.
Arrayfunction : This is actually the coolest trial I have ever heard of! I actually took part in a team research project for NASA's zero gravity undergraduate research project (which gets zero gravity by flying in steep parabolas rather than being in space) trying to look at how osteoblasts behaved differently to address bone loss for astronauts.
It is very interesting how so much of the biochemistry is affected by gravity (and how things like electrostatic interactions and Brownian motion become far more important in zero gravity). I am not 100% sure how this experiment will impact the organ printing industry commercially, but it will be a lot of fun to see what the results are!
Thanks for sharing